Noticias y Actividades de Rocket Pharmaceuticals

Rocket Pharmaceuticals es una de las ...

• Russell 3000;
• TOB Iconic 10,000.

Rocket Pharmaceuticals es una empresa que cotiza bajo el símbolo de cotización RCKT (US).

Ver el organigrama con sus 24 ejecutivos principales

Biografías más buscadas en Rocket Pharmaceuticals

• Gaurav Shah, Chief Executive Officer and President
• Gotham Makker, Independent Director
• Roderick Wong, Chairman of the Board

Recientes movimientos de ejecutivos en Rocket Pharmaceuticals

• Mikael Dolsten, se ha incorporado a la empresa como Director  (noticia publicada el 11 de septiembre de 2024).

Crear su alerta
para seguir los movimientos de los ejecutivos en Rocket Pharmaceuticals.

Rocket Pharmaceuticals tiene 1.833 competidores entre los que se incluyen Pfizer (Estados Unidos), Sanofi (Francia) y Eli Lilly (Estados Unidos).

Popular M&A news in Farmacia

• Imbria Pharmaceuticals acaba de anunciar una recaudación de fondos de 58 millones de dólares. (publicado el 10 de abril de 2025).
• Clario ha NRx Pharmaceuticals adquirido (publicado el 18 de marzo de 2025).
• Knight Therapeutics has announced the acquisition of Paladin Labs  (publicado el 12 de marzo de 2025).

Otros contactos sugeridos en el sector Farmacia

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets en Bristol-Myers Squibb
• Kristin Berkinsky - Chief Human Resources Officer en Adare Pharmaceuticals
• Paul Meister - Chairman of the Board en Amneal Pharmaceuticals

Saber más sobre el sector Farmacia

Últimos comunicados de prensa de Rocket Pharmaceuticals

• Rocket Pharmaceuticals Appoints Mayo Pujols as Chief Technical Officer and Strengthens Manufacturing Capabilities | Rocket Pharmaceuticals, Inc.
• Rocket Pharmaceuticals to Present at William Blair Biotech Focus Conference | Rocket Pharmaceuticals, Inc.
• Rocket Pharmaceuticals Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) | Rocket Pharmaceuticals, Inc.
• Rocket Pharmaceuticals Presents Positive Clinical Data from Danon Disease, Fanconi Anemia and Pyruvate Kinase Deficiency Programs at the 25th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) | Rocket Pharmaceuticals, Inc.
• Rocket Pharmaceuticals to Present at UBS Global Healthcare Conference | Rocket Pharmaceuticals, Inc.
• Rocket Pharmaceuticals Reports First Quarter 2022 Financial Results and Highlights Recent Progress | Rocket Pharmaceuticals, Inc.
• Rocket Pharmaceuticals to Present at the Bank of America Securities 2022 Global Healthcare Conference | Rocket Pharmaceuticals, Inc.
• View more press releases Close

Redes sociales sobre Rocket Pharmaceuticals

• Rocket Pharmaceuticals en Wikipedia, Google News y Yahoo Finance
• Rocket Pharmaceuticals en LinkedIn, Twitter y YouTube